NVIV
InVivo Therapeutics Holdings Corp
NVIV
NVIV
Delisted
NVIV was delisted on the 12th of February, 2024.
0 hedge funds and large institutions have $0 invested in InVivo Therapeutics Holdings Corp in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 4 closing their positions.
Holders
–
Holders Change
-4
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$0 |
| 2 |
VL
2
Vima LLC
Troy,
Michigan
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Goldman Sachs
New York
| – | – | -23,741 | Closed |
|
|
VL
2
Vima LLC
Troy,
Michigan
| – | – | -2 | Closed |
|
3
Barclays
London,
United Kingdom
| – | – | -2 | Closed |
|
|
SWM
4
Sugarloaf Wealth Management
Duluth,
Georgia
| – | – | -1 | Closed |
|